Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
NHS gets 12 years to roll out new weight-loss drug
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
'King Kong' weight loss drug to be given to less than 10% of eligible people in first rollout
Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other vital NHS services".
This weight loss drug helped people shed more pounds than Wegovy, new trial results show
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
NHS will deny weight loss jab to 90pc of obese patients
The NHS will deny 90 per cent of eligible obese patients the “King Kong” of weight loss jabs, citing budget pressures. The “difficult decision” by the National Institute for Health and Care Excellence (Nice),
Why your co-pay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Patients face 12-year wait for 'King Kong of weight loss drugs' on NHS
Mounjaro will be made available on the NHS but the rollout will be phased - only those with the highest need will get the jabs first meaning millions face a long wait
Yahoo
10h
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
It comes as a trial by
Mounjaro
manufacturer Eli Lilly – known as Surmount-5 – found patients on tirzepatide recorded a ...
pharmaphorum
23m
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
1h
Millions of Brits to be denied free ‘King-Kong’ weight-loss jabs in major U-turn – will you still qualify?
MILLIONS of Brits “will have to wait” to take a lifesaving fat loss jab dubbed the “King Kong of weight loss drugs”. Fewer ...
15h
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
22h
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
The Mirror
1d
NHS to prescribe ‘King Kong' weight loss jab Mounjaro to the most dangerously obese
A drug dubbed the “King Kong of
weight
loss
jabs” will start being given to the most dangerously obese in the New Year. However the NHS spending watchdog has announced
Mounjaro
will only be ...
2d
on MSN
Exclusive-Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Wegovy
Zepbound
Eli Lilly and Company
Feedback